COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,788 Articles (22,523 medRxiv, 8,265 bioRxiv)

Most recent first Previous |  Page 2433: Articles 24321-24330  | Next

COVID-19 scenarios for the United States
IHME COVID-19 Forecasting Team, , Hay, S. I.
10.1101/2020.07.12.20151191 — Posted: 2020-07-14 Discussion: Onsite
Public Opinions towards COVID-19 in California and New York on Twitter
Wang, X., Zou, C., Xie, Z., Li, D.
10.1101/2020.07.12.20151936 — Posted: 2020-07-14
Complexity signatures in the COVID-19 epidemic: power law behaviour in the saturation regime of fatality curves
Vasconcelos, G. L., Macedo, A. M. S., Duarte-Filho, G. C., Araujo, A. A., Ospina, R., Almeida, F. A. G.
10.1101/2020.07.12.20152140 — Posted: 2020-07-14
Evaluation of the Practicability of a Finger-Stick Whole-Blood SARS-Cov-2 Self-Test Adapted for the General Population.
prazuck, t., Phan Van, J., sinturel, F., levray, f., Elie, A., Camera, D., Pialloux, g.
10.1101/2020.07.13.20152660 — Posted: 2020-07-14
Impact of COVID-19 on 2020 US life expectancy for the Black and Latino populations
Andrasfay, T., Goldman, N.
10.1101/2020.07.12.20148387 — Posted: 2020-07-14 Discussion: Onsite
The natural history of symptomatic COVID-19 in Catalonia, Spain: a multi-state model including 109,367 outpatient diagnoses, 18,019 hospitalisations, and 5,585 COVID-19 deaths among 5,627,520 people
Burn, E., Tebe, C., Fernandez-Bertolin, S., Aragon, M., Recalde, M., Roel, E., Prats-Uribe, A., Prieto-Alhambra, D., Duarte-Salles, T.
10.1101/2020.07.13.20152454 — Posted: 2020-07-14
Novel surrogate virus neutralization test reveals low serum neutralizing anti-SARS-CoV-2-S antibodies levels in mildly affected COVID-19 convalescents
Bosnjak, B., Stein, S. C., Willenzon, S., Cordes, A. K., Puppe, W., Bernhardt, G., Ravens, I., Ritter, C., Schultze-Florey, C. R., Gödecke, N., Martens, J., Kleine-Weber, H., Hoffmann, M., Cossmann, A., Yilmaz, M., Pink, I., Hoeper, M. M., Behrens, G. M., Pöhlmann, S., Blasczyk, R., Schulz, T. F., Förster, R.
10.1101/2020.07.12.20151407 — Posted: 2020-07-14
Effect of statins on SARS-CoV-2 infection
Moeller, R., Zapatero-Belinchon, F. J., Lasswitz, L., Kirui, J., Brogden, G., Gunesch, A. P., Pietschmann, T., Wichmann, D., Kluge, S., Gerold, G.
10.1101/2020.07.13.20152272 — Posted: 2020-07-14
Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants
Sun, S., Lin, D., Operario, D.
10.1101/2020.07.13.20152678 — Posted: 2020-07-14
Linear epitope landscape of SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
Li, Y., Ma, M., Lei, Q., Wang, F., Sun, Z., Fan, X., Tao, S.-c.
10.1101/2020.07.13.20152587 — Posted: 2020-07-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).